BRUEX
Price
$16.53
Change
+$0.09 (+0.55%)
Updated
Jul 3 closing price
Net Assets
308.53M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

BRUEX vs VVIAX

Header iconBRUEX vs VVIAX Comparison
Open Charts BRUEX vs VVIAXBanner chart's image
MFS Blended Research Value Equity B
Price$16.53
Change+$0.09 (+0.55%)
VolumeN/A
Net Assets308.53M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
BRUEX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRUEX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUEX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. BRUEX (309M). VVIAX pays higher dividends than BRUEX: VVIAX (2.18) vs BRUEX (0.48). BRUEX was incepted earlier than VVIAX: BRUEX (10 years) vs VVIAX (25 years). BRUEX (1.60) is less costly to investors than VVIAX (0.05). BRUEX is a more actively managed with annual turnover of: 55.00 vs. VVIAX (9.00). BRUEX has a lower initial minimum investment than VVIAX: BRUEX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. BRUEX (2.85). VVIAX return over 5 years is better than : 80.13 vs. BRUEX (48.21).
BRUEXVVIAXBRUEX / VVIAX
Total Expense Ratio1.490.052,980%
Annual Report Gross Expense Ratio1.600.053,200%
Fund Existence10 years25 years-
Gain YTD8.6796.198140%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets309M189B0%
Annual Yield % from dividends0.482.1822%
Returns for 1 year2.8512.0324%
Returns for 3 years20.8935.1759%
Returns for 5 years48.2180.1360%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.